Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Coronavirus biology and replication: implications for SARS-CoV-2
Philip V’kovski, Annika Kratzel, Silvio Steiner, et al.
Nature Reviews Microbiology (2020) Vol. 19, Iss. 3, pp. 155-170
Open Access | Times Cited: 2854

Showing 1-25 of 2854 citing articles:

The biological and clinical significance of emerging SARS-CoV-2 variants
Kaiming Tao, Philip L. Tzou, Janin Nouhin, et al.
Nature Reviews Genetics (2021) Vol. 22, Iss. 12, pp. 757-773
Open Access | Times Cited: 985
Altered TMPRSS2 usage by SARS-CoV-2 Omicron impacts infectivity and fusogenicity
Bo Meng, Adam Abdullahi, Isabella A. T. M. Ferreira, et al.
Nature (2022) Vol. 603, Iss. 7902, pp. 706-714
Open Access | Times Cited: 977
Long COVID or Post-acute Sequelae of COVID-19 (PASC): An Overview of Biological Factors That May Contribute to Persistent Symptoms
Amy D. Proal, Michael B. VanElzakker
Frontiers in Microbiology (2021) Vol. 12
Open Access | Times Cited: 751
SARS-CoV-2 pathogenesis
Mart M. Lamers, Bart L. Haagmans
Nature Reviews Microbiology (2022) Vol. 20, Iss. 5, pp. 270-284
Open Access | Times Cited: 710
Functions of ROS in Macrophages and Antimicrobial Immunity
Marc Herb, Michael Schramm
Antioxidants (2021) Vol. 10, Iss. 2, pp. 313-313
Open Access | Times Cited: 436
Therapeutic strategies for COVID-19: progress and lessons learned
Guangdi Li, Rolf Hilgenfeld, Richard J. Whitley, et al.
Nature Reviews Drug Discovery (2023) Vol. 22, Iss. 6, pp. 449-475
Open Access | Times Cited: 420
mRNA-based therapeutics: powerful and versatile tools to combat diseases
Shugang Qin, Xiaoshan Tang, Yu‐Ting Chen, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 415
Circular RNA vaccines against SARS-CoV-2 and emerging variants
Liang Qu, Zongyi Yi, Yong Shen, et al.
Cell (2022) Vol. 185, Iss. 10, pp. 1728-1744.e16
Open Access | Times Cited: 401
Structures and functions of coronavirus replication–transcription complexes and their relevance for SARS-CoV-2 drug design
Brandon Malone, Nadya Urakova, Eric J. Snijder, et al.
Nature Reviews Molecular Cell Biology (2021) Vol. 23, Iss. 1, pp. 21-39
Open Access | Times Cited: 389
Role of Structural and Non-Structural Proteins and Therapeutic Targets of SARS-CoV-2 for COVID-19
Rohitash Yadav, Jitendra Kumar Chaudhary, Neeraj Jain, et al.
Cells (2021) Vol. 10, Iss. 4, pp. 821-821
Open Access | Times Cited: 385
COVID-19 and Cardiovascular Disease
Mina K. Chung, David A. Zidar, Michael R. Bristow, et al.
Circulation Research (2021) Vol. 128, Iss. 8, pp. 1214-1236
Open Access | Times Cited: 351
Effects of common mutations in the SARS-CoV-2 Spike RBD and its ligand, the human ACE2 receptor on binding affinity and kinetics
Michael I. Barton, Stuart A. MacGowan, Mikhail A. Kutuzov, et al.
eLife (2021) Vol. 10
Open Access | Times Cited: 341
Visualizing in deceased COVID-19 patients how SARS-CoV-2 attacks the respiratory and olfactory mucosae but spares the olfactory bulb
Mona Khan, Seung‐Jun Yoo, Marnick Clijsters, et al.
Cell (2021) Vol. 184, Iss. 24, pp. 5932-5949.e15
Open Access | Times Cited: 333
Multiple pathways for SARS-CoV-2 resistance to nirmatrelvir
Sho Iketani, Hiroshi Mohri, Bruce Culbertson, et al.
Nature (2022) Vol. 613, Iss. 7944, pp. 558-564
Open Access | Times Cited: 321
Virological characteristics of the SARS-CoV-2 Omicron BA.2 spike
Daichi Yamasoba, Izumi Kimura, Hesham Nasser, et al.
Cell (2022) Vol. 185, Iss. 12, pp. 2103-2115.e19
Open Access | Times Cited: 313
Pre-activated antiviral innate immunity in the upper airways controls early SARS-CoV-2 infection in children
Jennifer Loske, Jobst Röhmel, Soeren Lukassen, et al.
Nature Biotechnology (2021) Vol. 40, Iss. 3, pp. 319-324
Open Access | Times Cited: 310
CRISPR/Cas9 therapeutics: progress and prospects
Tianxiang Li, Yanyan Yang, Hongzhao Qi, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 307
Lessons learned 1 year after SARS-CoV-2 emergence leading to COVID-19 pandemic
Kelvin Kai‐Wang To, Siddharth Sridhar, Kelvin Hei‐Yeung Chiu, et al.
Emerging Microbes & Infections (2021) Vol. 10, Iss. 1, pp. 507-535
Open Access | Times Cited: 302
Efficacy and Safety of COVID-19 Vaccines: A Systematic Review and Meta-Analysis of Randomized Clinical Trials
Ali Pormohammad, Mohammad Zarei, Saied Ghorbani, et al.
Vaccines (2021) Vol. 9, Iss. 5, pp. 467-467
Open Access | Times Cited: 300
Reverse-transcribed SARS-CoV-2 RNA can integrate into the genome of cultured human cells and can be expressed in patient-derived tissues
Liguo Zhang, Alexsia Richards, M. Inmaculada Barrasa, et al.
Proceedings of the National Academy of Sciences (2021) Vol. 118, Iss. 21
Open Access | Times Cited: 265
An infectivity-enhancing site on the SARS-CoV-2 spike protein targeted by antibodies
Yafei Liu, Wai Tuck Soh, Jun-ichi Kishikawa, et al.
Cell (2021) Vol. 184, Iss. 13, pp. 3452-3466.e18
Open Access | Times Cited: 262
Minimally instrumented SHERLOCK (miSHERLOCK) for CRISPR-based point-of-care diagnosis of SARS-CoV-2 and emerging variants
Helena de Puig, Rose Lee, Devora Najjar, et al.
Science Advances (2021) Vol. 7, Iss. 32
Open Access | Times Cited: 255
Nasal ciliated cells are primary targets for SARS-CoV-2 replication in the early stage of COVID-19
Ji Hoon Ahn, JungMo Kim, Seon Pyo Hong, et al.
Journal of Clinical Investigation (2021) Vol. 131, Iss. 13
Open Access | Times Cited: 249
Correlates of protection against SARS‐CoV‐2 infection and COVID‐19 disease
David Goldblatt, Galit Alter, Shane Crotty, et al.
Immunological Reviews (2022) Vol. 310, Iss. 1, pp. 6-26
Open Access | Times Cited: 241
Structural basis of ribosomal frameshifting during translation of the SARS-CoV-2 RNA genome
Pramod R. Bhatt, Alain Scaiola, Gary Loughran, et al.
Science (2021) Vol. 372, Iss. 6548, pp. 1306-1313
Open Access | Times Cited: 234
Page 1 - Next Page

Scroll to top